PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

These four top dividend stocks offer dependable passive income streams and solid total return, and they are too cheap to ...

Since the holidays, there's been an uptick in cases of flu and other viruses in the region, health officials say.

Investors concerned about sticky inflation should look to high-yield dividend stocks in sectors that will continue to ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

It’s been estimated that about 400 million people worldwide have had long COVID. Some researchers say that number is much ...

A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

Recent studies suggest that women and patients with multiple COVID-19 infections are at a higher risk of developing long COVID. Here are four other studies.

Paxlovid use was associated with lower rates of hospitalization and death, particularly among older adults, a new study finds ...

Long COVID remains a major health challenge for millions of people, with symptoms like brain fog lingering for months after ...